Year : 2014 | Volume
: 8 | Issue : 2 | Page : 91--99
A study of IL-6, IL-8, and TNF-α as inflammatory markers in COPD patients
Wafaa S El-Shimy, Ayman S El-Dib, Hala M Nagy, Wael Sabry
Chest and Clinical Pathology Department, Kafr EL-Shek Chest Hospital, Tanta University, Tanta, Egypt
Aim To assess the diagnostic value of interleukin 6 (IL-6), IL-8 and tumor necrosis factor-α (TNF-α) as inflammatory markers in chronic obstructive pulmonary disease (COPD) patients.
Methods and results IL-6, IL-8 and TNF-α levels were measured by ELISA in the serum and the bronchoalveolar lavage (BAL) in 10 control participants and 25 mild and moderate COPD patients, whereas 25 patients with severe COPD were studied for the serum level of these inflammatory biomarkers.
The mean value and SD of BAL and serum IL-6, IL-8 and TNF-α levels were significantly higher in COPD patients when compared with control participants; the serum level of these biomarkers were also significantly higher in severe compared with mild and moderate COPD patients.
Conclusion Increased srum and/or BAL IL-6, IL-8 and TNF-α can be used as biomarkers of the systemic inflammatory response in COPD patients, and their levels are correlated with the severity of COPD. Egypt J Broncho 2014 8:91-99
2014 Egyptian Journal of Bronchology.
Ayman S El-Dib
Villa ElKhoalka, Foad Yousef Awess St, Bolkaly, Alexandria
|How to cite this article:|
El-Shimy WS, El-Dib AS, Nagy HM, Sabry W. A study of IL-6, IL-8, and TNF-α as inflammatory markers in COPD patients.Egypt J Bronchol 2014;8:91-99
|How to cite this URL:|
El-Shimy WS, El-Dib AS, Nagy HM, Sabry W. A study of IL-6, IL-8, and TNF-α as inflammatory markers in COPD patients. Egypt J Bronchol [serial online] 2014 [cited 2020 Feb 23 ];8:91-99
Available from: http://www.ejbronchology.eg.net/article.asp?issn=1687-8426;year=2014;volume=8;issue=2;spage=91;epage=99;aulast=El-Shimy;type=0